Newscrate logo

Browse the latest gene therapy news online for free

Search results for "gene therapy"

Brothers with rare genetic disease receive gene therapy
Brothers with rare genetic disease receive gene therapy

An Illinois family pushed for both boys to receive the potentially life changing medical treatment after one was approved and the other initially denied by their insurer. Now both boys have received the gene therapy and the family is together in time for Christmas. NBC News’ Maggie Vespa reports. Read more

Nbc News - Dec 24
New gene therapy drugs can save lives, but many cost millions
New gene therapy drugs can save lives, but many cost millions

A new class of life-saving drugs is helping children who once had no hope. But some carry a price tag of millions for a single dose, and the American healthcare system hasn't figured out how to pay. Read more

Cbs News - Dec 15
$2 million gene therapy could save her baby's life. But insurance wouldn't pay.
$2 million gene therapy could save her baby's life. But insurance wouldn't pay.

A new class of life-saving drugs is helping children who once had no hope. But some carry a price tag of millions for a single dose, and the American health care system hasn't figured out how to pay. Read more

Cbs News - Dec 15
Eli Lilly’s Adverum move: The future of ocular gene therapy at the 4th Ophthalmic Drug Delivery Summit
Eli Lilly’s Adverum move: The future of ocular gene therapy at the 4th Ophthalmic Drug Delivery Summit

The race to develop safer, longer lasting, and less invasive treatments is accelerating, and at the heart of that challenge lies drug delivery. Read more

Medical News - Nov 27
Boy with rare condition amazes doctors after world-first gene therapy
Boy with rare condition amazes doctors after world-first gene therapy

Oliver has an inherited condition called Hunter syndrome, which causes progressive damage to the body and brain. Read more

The Bbc - Nov 24
Passage Bio Pushes Toward Key 2026 Milestones as Gene Therapy Program Accelerates
Passage Bio Pushes Toward Key 2026 Milestones as Gene Therapy Program Accelerates

PHILADELPHIA, PA — Passage Bio, Inc. (Nasdaq: PASG) reported third-quarter financial results and outlined steady progress across its upliFT-D gene therapy program, positioning the company for critical regulatory and clinical ... Read more

Mychesco - Nov 18
Cell and Gene Therapy in Parkinson's Disease Treatment Market Size in the 7MM is expected to grow by 2034, estimates DelveInsight
Cell and Gene Therapy in Parkinson's Disease Treatment Market Size in the 7MM is expected to grow by 2034, estimates DelveInsight

DelveInsight's comprehensive report titled "Cell and Gene Therapy in Parkinson's disease Market Insights, Epidemiology, and Market Forecast - 2034" offers a detailed analysis of Cell and Gene Therapy in Parkinson's disease. The report analyzes the existing treatment practices and unmet Read more

Openpr.com - Nov 16
FDA adds strongest warning to Sarepta gene therapy
FDA adds strongest warning to Sarepta gene therapy

The Food and Drug Administration is adding a new warning to a gene therapy linked to two patient deaths earlier this year. Sarepta Therapeutics' Elevidys will carry the FDA's strongest warning label about the risks of liver damage and liver failure, the agency said Friday. The action follows mont... Read more

Apnews - Nov 14
Emerging Trends to Reshape the Global Cell And Gene Therapy Supply Chain/Logistics Market: Advancements In Technology Propel Cell And Gene Therapy Logistics as a Key Influencer
Emerging Trends to Reshape the Global Cell And Gene Therapy Supply Chain/Logistics Market: Advancements In Technology Propel Cell And Gene Therapy Logistics as a Key Influencer

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.Cell And Gene Therapy Supply Chain/Logistics Market Size Valuation Forecast: What Will the Market Be Worth by 2025?The Read more

Openpr.com - Nov 14
Vitamin D's Heart Prevention Win; ATTR Depleter Does So-So; Gene Therapy Trial Hold
Vitamin D's Heart Prevention Win; ATTR Depleter Does So-So; Gene Therapy Trial Hold

(MedPage Today) -- Personalized vitamin D supplementation -- often requiring 5,000 IU of vitamin D each day -- did prove to have secondary prevention benefits in the TARGET-D randomized trial presented at the American Heart Association meeting... Read more

Medpagetoday - Nov 11